Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine if vitamin D supplementation increases the level
of a protein that may be involved in decreasing the risk of esophageal cancer in patients
with Barrett's esophagus. Subjects with Barrett's esophagus will take vitamin D
supplementation for 2-12 weeks depending on the severity of their condition, and receive an
upper endoscopy procedure before and after vitamin D supplementation trial.
Phase:
Early Phase 1
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Treatments:
Cholecalciferol Ergocalciferols Metformin Omeprazole Vitamin D Vitamins